Paraoxonase 2 (PON2) in the mouse central nervous system: A neuroprotective role?

Toxicology and Applied Pharmacology

Volumn 256, Issue 3, 2011, Pages 369-378

  Giordano, Gennaro ^a   Cole, Toby B ^a   Furlong, Clement E ^a   Costa, Lucio G ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

Author keywords

Antioxidant; Paraoxonase 2; PON2; Striatum

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; GLUTATHIONE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN REGION; BRAIN STEM; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; MALE; MICROSOME; MITOCHONDRION; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BLOTTING, WESTERN; BRAIN; CORPUS STRIATUM; FEMALE; GLUTATHIONE; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; NUCLEUS ACCUMBENS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBCELLULAR FRACTIONS; SUBSTANTIA NIGRA;

MUS;

EID: 80855144241     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.02.014     Document Type: Article

References (44)

1. Ahmad S., Scott J.E. Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression. Biochem. Biophys. Res. Commun. 2010, 397:441-446.
2. Altenhofer S., Witte I., Teiber J.F., Wilgenbus P., Pautz A., Li H., Daiber A., Witan H., Clement A.M., Forstermann U., Horke S. One enzyme, two functions. PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity. J. Biol. Chem. 2010, 285:24398-24403.
3. Blomgren K., Leist M., Groc L. Pathological apoptosis in the developing brain. Apoptosis 2007, 12:993-1010.
4. Cox B., Emili A. Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat. Protoc. 2006, 1:1872-1878.
5. Darte C., Beaufay H. Analytical subcellular fractionation of cultivated mouse resident peritoneal macrophages. J. Exp. Med. 1983, 157:1208-1228.
6. Devarajan, A., Bourquard, N., Hama, S., Navab, M., Grijalva, V.R., Morvardi, S., Clarke, C., Vergnes, L., Reue, K., Teiber, J.F., Reddy, S.T., 2011. Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid. Redox Signal. 14, 341-351.
7. Draganov D.I., La Du B.N. Pharmacogenetics of paraoxonase: a brief review. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:78-88.
8. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., La Du B.N. Human paraoxonases (PON1, PON2 and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 2005, 46:1239-1247.
9. Floor E. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease. Cell. Mol. Biol. (Noisy-le-grand) 2000, 46:709-720.
10. Giordano G., White C.C., McConnachie L.A., Fernandez C., Kavanagh T.J., Costa L.G. Neurotoxicity of domoic acid in cerebellar granule neurons in a genetic model of glutathione deficiency. Mol. Pharmacol. 2006, 70:2116-21126.
11. Giordano G., Kavanagh T.J., Costa L.G. Neurotoxicity of a polybrominated diphenyl ether mixture (DE-71) in mouse neurons and astrocytes is modulated by intracellular glutathione levels. Toxicol. Appl. Pharmacol. 2008, 232:161-168.
12. Hayashi M. Oxidative stress in developmental brain disorders. Neuropathology 2009, 29:1-8.
13. Higgins G.C., Beart P.M., Shin Y.S., Chen M.J., Cheung N.S., Nagley P. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J. Alzheimers Dis. 2010, 20(Suppl. 2):S453-S473.
14. Horke S., Witte I., Wilgenbus P., Kruger M., Starnd D., Forstermann U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 2007, 115:2055-2064.
15. Horke S., Witte I., Altenhoffer S., Wilgenbus P., Goldeck M., Forstermann U., Xiao J., Kramer G.L., Haines D.C., Chowdhary P.K., Haley R.W., Teiber J.F. Paraoxonase-2 is down regulated by the Pesudomonas aeruginosa quorum-sensing signal N-(3-oxododecanyl)-l-homoserine lactone and attenuates oxidative stress induced by pyocyanin. Biochem. J. 2010, 426:73-83.
16. Huang S.C., Giordano G., Costa L.G. Comparative cytotoxicity and intracellular accumulation of five polybrominated diphenyl ether congeners in mouse cerebellar granule neurons. Toxicol. Sci. 2010, 114:124-132.
17. Klintworth H., Garden G., Xia Z. Rotenone and paraquat do not directly activate microglia or induce inflammatory cytokine release. Neurosci. Lett. 2009, 462:1-5.
18. Levy E., Trudel K., Bendayan M., Seidman E., Delvin E., Elchebly M., Lavoie J.C., Precourt L.P., Amre D., Sinnett D. Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of human and rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G1252-G1261.
19. Li W.F., Matthews C., Disteche C.M., Costa L.G., Furlong C.E. Paraoxonase (Pon1) in mice: sequencing, chromosomal localization and developmental expression. Pharmacogenetics 1997, 7:137-144.
20. Li W.F., Costa L.G., Richter R.J., Hagen T., Shih D.M., Tward A., Lusis A.J., Furlong C.E. Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates. Pharmacogenetics 2000, 10:767-779.
21. Mackness B., Beltran-Debon R., Aragones G., Joven J., Camps J., Mackness M. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 2010, 62:480-482.
22. Marsillach J., Mackness B., Mackness M., Riu F., Beltran R., Joven J., Camps J. Immunohistochemical analysis of paraoxonase-1, 2 and 3 expression in normal mouse tissues. Free Radic. Biol. Med. 2008, 45:146-157.
23. Marsillach J., Aragonès G., Mackness B., Mackness M., Rull A., Beltrán-Debón R., Pedro-Botet J., Alonso-Villaverde C., Joven J., Camps J. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment. Lipids Health Dis. 2010, 9:46. (PMCID: PMC 2877049).
24. Mochizuki H., Scherer S.W., Xi T., Nickle D.C., Majer M., Huizenga J.J., Tsui L.C., Prochazka M. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 1998, 213:149-157.
25. Ng C.J., Wadleigh D.J., Gangopadhyyay A., Hama S., Grijalva V.R., Navab M., Fogelman A.M., Reddy S.T. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 2001, 276:44444-44449.
26. Ng C.J., Bourquard N., Grijalva V., Hama S., Shih D.M., Navab M., Fogelman A.M., Lusis A.J., Young S., Reddy S.T. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins. Antiatherogenic role for paraoxonase-2. J. Biol. Chem. 2006, 281:29491-29500.
27. Precourt L.P., Seidman E., Delvin E., Amre D., Deslandres C., Dominguez M., Sinnett D., Levy E. Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members. Int. J. Biochem. Mol. Biol. 2009, 41:1628-1637.
28. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33:498-507.
29. Ramsby M.L., Makowski G.S. Differential detergent fractionation of eukaryotic cells. Analysis by two-dimensional gel electrophoresis. Methods Mol. Biol. 1999, 112:53-66.
30. Reynolds A., Chad L., Mosley R.L., Geldelman H.E. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol. 2007, 82:297-325.
31. Rice M.E., Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 1998, 82:1213-1223.
32. Rosenblatt M., Draganov D., Watson C.E., Bisgaier C.L., La Du B.N., Aviram M. Mouse macrophage paraoxonase-2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2003, 23:468-474.
33. Rothem L., Hartman C., Dahan A., Lachter J., Eliakim R., Shamir R. Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized in the endoplasmic reticulum. Free Radic. Biol. Med. 2007, 43:730-739.
34. Sayre L.M., Perry G., Smith M.A. Oxidative stress and neurotoxicity. Chem. Res. Toxicol. 2008, 21:172-188.
35. Shadrina M.I., Slominski P.A., Limborska S.A. Molecular mechanisms of pathogenesis of Parkinson's disease. Int. Rev. Cell Mol. Biol. 2010, 281:229-266.
36. Shamir R., Hartman C., Karry R., Pavlotzky E., Eliakim R., Lachter J., Suissa A., Aviram M. Paraoxonases (PONs) 1, 2 and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. Free Radic. Biol. Med. 2005, 39:336-344.
37. Shiner M., Fuhrman B., Aviram M. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-dependent mechanism during monocytes differentiation into macrophages. Free Radic. Biol. Med. 2004, 37:2052-2063.
38. Sola A., Rogido M.R., Deulofeut R. Oxygen as a neonatal health hazard: call for detente in clinical practice. Acta Pediatr. 2007, 96:801-812.
39. Stoltz D.A., Ozer E.A., Ng C.J., Yu J.M., Reddy S.T., Lusis A.J., Bourquard N., Parsek M.R., Zabner J., Shih D.M. Paraoxonase-2 deficiency enhances Psudomonas aeruginosa quorum sensing in murine tracheal epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L852-L860.
40. Stoltz D.A., Ozer E.A., Recker T.J., Estin M., Yang X., Shih D.M., Lusis A.J., Zabner J. A common mutation in paraoxonase-2 results in impaired lactonase activity. J. Biol. Chem. 2009, 284:35564-35571.
41. Sutherland W.H., Manning P.J., de Jong S.A., Allum A.R., Jones S.D., Williams S.M. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women. Metabolism 2001, 50:319-324.
42. Teiber J.F., Billecke S.S., La Du B.N., Draganov D.I. Estrogen esters as substrates for human paraoxonases. Arch. Biochem. Biophys. 2007, 461:24-29.
43. Teiber J.F., Horke S., Haines D.C., Chowdhary P.K., Xiao J., Kramer G.L., Haley R.W., Draganov D.I. Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-l-homoserine lactone. Infect. Immun. 2008, 76:2512-2519.
44. (2+)-dependent translocation from cytoplasm to membranes and cytoskeleton. J. Immunol. 1996, 156:1247-1254.